LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 325 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $83,289 | -25.2% | 1,390 | -10.0% | 0.00% | – |
| Q2 2023 | $111,395 | -3.2% | 1,545 | -1.3% | 0.00% | – |
| Q1 2023 | $115,120 | +20.1% | 1,565 | +9.1% | 0.00% | – |
| Q4 2022 | $95,857 | -12.9% | 1,435 | +13.0% | 0.00% | – |
| Q3 2022 | $110,000 | +41.0% | 1,270 | +45.1% | 0.00% | – |
| Q2 2022 | $78,000 | -42.2% | 875 | -27.6% | 0.00% | – |
| Q1 2022 | $135,000 | -22.9% | 1,208 | +6.5% | 0.00% | – |
| Q4 2021 | $175,000 | +24.1% | 1,134 | +12.4% | 0.00% | – |
| Q3 2021 | $141,000 | +67.9% | 1,009 | +58.9% | 0.00% | – |
| Q2 2021 | $84,000 | -16.8% | 635 | -3.6% | 0.00% | – |
| Q1 2021 | $101,000 | +68.3% | 659 | +11.3% | 0.00% | – |
| Q4 2020 | $60,000 | -25.0% | 592 | -29.4% | 0.00% | – |
| Q3 2020 | $80,000 | -23.8% | 838 | -10.7% | 0.00% | – |
| Q2 2020 | $105,000 | +32.9% | 938 | -13.5% | 0.00% | – |
| Q1 2020 | $79,000 | -38.8% | 1,084 | -13.1% | 0.00% | – |
| Q4 2019 | $129,000 | +19.4% | 1,248 | +14.6% | 0.00% | – |
| Q3 2019 | $108,000 | -57.5% | 1,089 | -51.2% | 0.00% | – |
| Q2 2019 | $254,000 | +2.0% | 2,232 | +13.3% | 0.00% | – |
| Q1 2019 | $249,000 | -5.3% | 1,970 | +1.6% | 0.00% | – |
| Q4 2018 | $263,000 | -96.7% | 1,939 | -93.4% | 0.00% | -100.0% |
| Q3 2018 | $8,079,000 | -1.5% | 29,439 | -25.6% | 0.01% | 0.0% |
| Q2 2018 | $8,199,000 | +25.6% | 39,583 | +0.1% | 0.01% | +33.3% |
| Q1 2018 | $6,527,000 | +20.1% | 39,524 | -0.5% | 0.01% | +20.0% |
| Q4 2017 | $5,436,000 | +46.4% | 39,705 | +45.6% | 0.01% | +25.0% |
| Q3 2017 | $3,713,000 | +206.6% | 27,265 | +173.3% | 0.00% | +300.0% |
| Q2 2017 | $1,211,000 | +20.5% | 9,975 | +5.1% | 0.00% | 0.0% |
| Q1 2017 | $1,005,000 | -28.4% | 9,492 | -31.3% | 0.00% | -50.0% |
| Q4 2016 | $1,403,000 | -24.8% | 13,808 | -24.5% | 0.00% | 0.0% |
| Q3 2016 | $1,866,000 | -16.4% | 18,281 | -2.2% | 0.00% | -33.3% |
| Q2 2016 | $2,231,000 | +13.1% | 18,694 | +1.5% | 0.00% | +50.0% |
| Q1 2016 | $1,973,000 | +44.2% | 18,418 | +45.9% | 0.00% | 0.0% |
| Q4 2015 | $1,368,000 | +27.9% | 12,628 | +1.2% | 0.00% | +100.0% |
| Q3 2015 | $1,070,000 | -13.3% | 12,479 | +2.0% | 0.00% | 0.0% |
| Q2 2015 | $1,234,000 | +65.6% | 12,237 | +26.6% | 0.00% | 0.0% |
| Q1 2015 | $745,000 | +90.1% | 9,669 | +31.1% | 0.00% | – |
| Q4 2014 | $392,000 | -23.9% | 7,373 | -32.7% | 0.00% | -100.0% |
| Q3 2014 | $515,000 | -40.3% | 10,954 | -20.8% | 0.00% | 0.0% |
| Q2 2014 | $862,000 | -13.9% | 13,839 | -7.0% | 0.00% | 0.0% |
| Q1 2014 | $1,001,000 | +43.6% | 14,880 | +12.3% | 0.00% | 0.0% |
| Q4 2013 | $697,000 | -20.4% | 13,255 | -34.5% | 0.00% | 0.0% |
| Q3 2013 | $876,000 | 0.0% | 20,232 | -13.6% | 0.00% | 0.0% |
| Q2 2013 | $876,000 | – | 23,420 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |